Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 05, 2026
MDWerks Announces First Shipment of Wood Chip By-Product to Global Health and Beauty Company
01:00pm, Thursday, 03'rd Jul 2025
GREEN COVE SPRINGS, Fla., July 03, 2025 (GLOBE NEWSWIRE) -- MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable
Insurance costs for Strait of Hormuz 'all over the place', says Global Ship Lease CEO
12:04pm, Thursday, 03'rd Jul 2025
Tom Lister, the CEO of Global Ship Lease, discusses the impact of Trump's tariffs and the ongoing crises in the Middle East on global shipping.
When Adding Alternatives, Don't Overlook Global Macro
10:15am, Thursday, 03'rd Jul 2025
Advisors and investors wanting to diversify their portfolios in the second half of 2025 shouldn't overlook the Unlimited HFGM Global Macro ETF (HFGM). With its focus on macroeconomic trends, the strat
Venture Global Announces 20-Year Sales and Purchase Agreement with PETRONAS
08:59am, Thursday, 03'rd Jul 2025
ARLINGTON, Va.--(BUSINESS WIRE)--Venture Global Announces 20-Year Sales and Purchase Agreement with PETRONAS.
XCF Global Appoints BTIG as Capital Markets Advisor
07:45am, Thursday, 03'rd Jul 2025
BTIG to provide strategic advice on capital markets positioning, institutional engagement, and investor outreach Appointment supports XCF's efforts to build long-term shareholder value following Nasda
Thermal Energy Announces Additional $4.1 Million Contract with Global Pharmaceutical Leader
07:01am, Thursday, 03'rd Jul 2025
Canadian cleantech firm hired to design, implement and commission a turn-key heat recovery project at one of the Fortune 500-listed customer's U.S. manufacturing facilities Ottawa, Ontario--(Newsfile
CI Global Asset Management Announces Changes to Four Investment Funds
07:00am, Thursday, 03'rd Jul 2025
TORONTO--(BUSINESS WIRE)---- $CGRN #CIFinancial--CI Global Asset Management announces risk ratings changes for three investment funds and a name change for CMCX.
Change in Huhtamaki's Global Executive Team
02:00am, Thursday, 03'rd Jul 2025
HUHTAMÄKI OYJ STOCK EXCHANGE RELEASE 3.7.2025 AT 09:00 EEST Change in Huhtamaki's Global Executive Team Ingolf Thom, Executive Vice President, HR and Safety, and member of Huhtamaki's Globa
Helium One Global Ltd Announces Appointment of New Non-Executive Director
02:00am, Thursday, 03'rd Jul 2025
LONDON, UNITED KINGDOM / ACCESS Newswire / July 3, 2025 / Helium One Global (AIM:HE1), the primary helium explorer in Tanzania with a 50% working interest in the Galactica-Pegasus helium development p
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001
07:09pm, Wednesday, 02'nd Jul 2025
Highlights: Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, prov
Coventry Responds to Baseless Lawsuit by Abacus Global Management, Inc.
03:06pm, Wednesday, 02'nd Jul 2025
FORT WASHINGTON, Pa. , July 2, 2025 /PRNewswire/ -- Coventry, the leader and creator of the secondary market for life insurance, today released the following statement: "Abacus's (NASDAQ: ABL) lawsui
Carrier Global: A Focused Portfolio To Capitalize On Strong Secular Tailwinds
01:29pm, Wednesday, 02'nd Jul 2025
I rate Carrier Global a buy, driven by its transformation into a pure-play climate/energy solutions leader with strong structural growth drivers. CARR's focused portfolio and top-three market position
Here's Why Investors Should Retain Global Payments Stock for Now
12:52pm, Wednesday, 02'nd Jul 2025
GPN eyes long-term gains with the Worldpay deal and strong cash flow, even as shares drop 26.9% year to date.
JCR Pharmaceuticals Announces the Achievement of Enrollment in the JR-141 Global Phase III Clinical Trial
11:12am, Wednesday, 02'nd Jul 2025
HYOGO, Japan--(BUSINESS WIRE)--JCR today announced that it achieved the enrollment of the target number of participants in the global Phase III clinical trial of JR-141.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL
10:00am, Wednesday, 02'nd Jul 2025
NEW YORK , July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are
